Sickle Cell Gene Therapy: Real-World Outcomes from First 50 Patients

WHY IT MATTERS

Real-world results matching trial data. Gene therapy delivering on its promise.

Early real-world data shows vaso-occlusive crisis elimination in 89% of patients at 6 months post-treatment.

Related conditions